National Comprehensive Cancer Network



About NCCN

MEDIA ADVISORY: NCCN to Unveil Oncology Value Tool at Oct. 16 Press Conference in San Francisco

MEDIA ONLY

 

 

 

 

Media Advisory

NCCN to Unveil Oncology Value Tool at Oct 16 Press Conference in San Francisco

Press Conference and Media Panel:       

NCCN Guidelines with NCCN Evidence Blocks:

A View of the Patient-Empowered Cancer Conversation

 

EDITORS: For an advance view of the NCCN Evidence Blocks, contact Katie Kiley Brown at brown@nccn.org

 

WHEN: 

Friday, October 16, 2015

11:00 AM – 12:00 PM Pacific Time – Live or WebEx

 

WHAT: To further empower patients to make treatment decisions in line with their values, the National Comprehensive Cancer Network (NCCN)  will introduce a new infographic tool for evaluating treatment decisions  [its new value initiative]—the NCCN Evidence Blocks—at a press conference at the start of the NCCN 10th Annual Congress: Hematologic Malignancies.

The new NCCN Guidelines with NCCN Evidence Blocks enable physicians and patients to speak the same language of choice and value. Robert W. Carlson, MD, Chief Executive Officer, NCCN, will demonstrate how the five key value considerations displayed in the NCCN Evidence Blocks—Efficacy, Safety, Quality and Quantity of evidence, Consistency of evidence, and Affordability—can be used to evaluate recommended interventions in cancer care.

By adding affordability to NCCN’s existing criteria of efficacy, toxicity, and evidence for evaluating treatment options, patients will be empowered to identify, alongside their physician, optimal treatment based on clinical and economic considerations that are of most value to them. 

Following opening remarks, a panel of physicians and patients will discuss the challenges and benefits presented by this new physician/patient dynamic in shared decision-making.

 

WHO: 

Moderator:

Victoria Colliver, Health Reporter, San Francisco Chronicle; Member, Association of Health Care Journalists

Panelists:    

Robert W. Carlson, MD, Chief Executive Officer, National Comprehensive Cancer Network      

George Somlo, MD, Professor, Department of Hematology & Hematopoietic Cell Transplantation and Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center; NCCN Guidelines Panel Member for Multiple Myeloma

Marta Nichols, Cancer Survivor and Advocate; Emeritus Board Member, Bay Area Cancer Connections;  Council Member, California Breast Cancer Research Council; Vice President, Investor Relations, GoDaddy   

Don Orosco, 25-year survivor of multiple myeloma; President and Chief Financial Officer, Orosco and Associates, Inc. and DBO Motor Racing Enterprises, Inc.; Internationally Recognized Vintage Racer, Automotive Historian, Specialized Vintage Race Parts Manufacturer and Owner, Monterey Speed and Sport

 

WHERE:         

NCCN 10th Annual Congress: Hematologic Malignancies
San Francisco Marriott Marquis, 780 Mission Street, San Francisco, CA 94103       

 

CONTACT:    

Katie Kiley Brown, NCCN, brown@nccn.org
215.690.0238 (office), 610.573.3893 (cell on-site)

To register for the live event, contact Katie Kiley Brown.
To register for the WebEx, visit    https://nccn.webex.com/nccn/onstage/g.php?MTID=ef52c0e04c258563df9fdb5e45ec48c4c

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital